{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:00:59Z","timestamp":1783141259471,"version":"3.54.6"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s11940-013-0239-4","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T08:46:32Z","timestamp":1374655592000},"page":"410-423","source":"Crossref","is-referenced-by-count":40,"title":["Update on Treatment of Essential Tremor"],"prefix":"10.1007","volume":"15","author":[{"given":"Theresa A.","family":"Zesiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Staffetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"key":"239_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004691-199603000-00004","volume":"13","author":"RJ Elble","year":"1996","unstructured":"Elble RJ. Central mechanism of tremor. J Clin Neurophysiol. 1996;13:133\u201344.","journal-title":"J Clin Neurophysiol"},{"key":"239_CR2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mds.10376","volume":"18","author":"J Benito-Leon","year":"2003","unstructured":"Benito-Leon J, Bermejo-Pareja F, Morales JM, et al. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord. 2003;18:389\u201394.","journal-title":"Mov Disord"},{"key":"239_CR3","volume-title":"Essential tremor: an epidemiological, clinical, and genetic study [Dissertation]","author":"I Rautakorpi","year":"1978","unstructured":"Rautakorpi I. Essential tremor: an epidemiological, clinical, and genetic study [Dissertation]. Turku: University of Turku; 1978."},{"issue":"1","key":"239_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.870130105","volume":"13","author":"ED Louis","year":"1998","unstructured":"Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world. Mov Disord. 1998;13(1):5\u201310.","journal-title":"Mov Disord"},{"issue":"14","key":"239_CR5","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/mds.22755","volume":"24","author":"G Deuschl","year":"2009","unstructured":"Deuschl G, Elble R. Essential tremor \u2013 neurodegenerative or nondegenerative disease towards a working definition of ET. Mov Disord. 2009;24(14):2033\u201341.","journal-title":"Mov Disord"},{"issue":"2","key":"239_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.870090212","volume":"9","author":"C Singer","year":"1994","unstructured":"Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. Mov Disord. 1994;9(2):193\u20136.","journal-title":"Mov Disord"},{"key":"239_CR7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","volume":"10","author":"G Deuschl","year":"2011","unstructured":"Deuschl G, Raethjen J, Hellriegel H, et al. Treatment of patients with essential tremor. Lancet Neurol. 2011;10:148\u201361. This paper compares the efficacy of available treatments for ET","journal-title":"Lancet Neurol"},{"key":"239_CR8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s004150070053","volume":"247","author":"A Schrag","year":"2000","unstructured":"Schrag A, M\u00fcnchau A, Bhatia KP, et al. Essential tremor: an overdiagnosed condition? J Neurol. 2000;247:955\u20139.","journal-title":"J Neurol"},{"key":"239_CR9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archneur.63.8.1100","volume":"63","author":"S Jain","year":"2006","unstructured":"Jain S, Lo SE, Louis ED. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol. 2006;63:1100\u20134.","journal-title":"Arch Neurol"},{"issue":"Suppl 3","key":"239_CR10","first-page":"2","volume":"13","author":"G Deuschl","year":"1998","unstructured":"Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13 Suppl 3:2\u201323.","journal-title":"Mov Disord"},{"key":"239_CR11","first-page":"91","volume":"2","author":"ED Louis","year":"2011","unstructured":"Louis ED. Treatment of essential tremor: are there issues we are overlooking? Front Neurol. 2011;2:91.","journal-title":"Front Neurol"},{"issue":"7365","key":"239_CR12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(64)90746-9","volume":"284","author":"AB Herring","year":"1964","unstructured":"Herring AB. Action of Pronethalol on Parkinsonian Tremor. Lancet. 1964;284(7365):892.","journal-title":"Lancet"},{"key":"239_CR13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp.36.4.618","volume":"36","author":"MH Morgan","year":"1973","unstructured":"Morgan MH, Hewer RL, Cooper R. Effect of the beta adrenergic blocking agent propranolol on essential tremor. J Neurol Neurosurg Psychiatry. 1973;36:618\u201324.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"239_CR14","unstructured":"Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: therapies for essential tremor. Report of the Quality Standards Subcommittee of the American Academy of Neurology. 2005;64:2008\u201320."},{"key":"239_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.35.1.108","volume":"35","author":"WC Koller","year":"1985","unstructured":"Koller WC. Long-acting propranolol in essential tremor. Neurology. 1985;35:108\u201310.","journal-title":"Neurology"},{"key":"239_CR16","unstructured":"Physicians' desk reference. 66th ed. Montvale, NJ: Thomson PDR; 2012."},{"key":"239_CR17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/jnnp.44.10.932","volume":"44","author":"S Calzetti","year":"1981","unstructured":"Calzetti S, Findley LJ, Pisani F, et al. Phenylethylmalonamide in essential tremor: a double blind controlled study. J Neurol Neurosurg Psychiatry. 1981;44:932\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"239_CR18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jnnp.48.9.911","volume":"48","author":"LJ Findley","year":"1985","unstructured":"Findley LJ, Cleeves L, Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry. 1985;48:911\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"239_CR19","first-page":"383","volume":"17","author":"P O\u2019Suilleabhain","year":"2002","unstructured":"O\u2019Suilleabhain P, Dewey RB. Randomized trial comparing primidone initiation schedules for treating essential tremor. Mov Disord. 2002;17:383\u20136.","journal-title":"Mov Disord"},{"issue":"1","key":"239_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9149(75)90560-3","volume":"35","author":"JA Udall","year":"1975","unstructured":"Udall JA. Clinical implications of warfarin interactions with five sedatives. Am J Cardiol. 1975;35(1):67\u201371.","journal-title":"Am J Cardiol"},{"key":"239_CR21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","volume":"66","author":"WG Ondo","year":"2006","unstructured":"Ondo WG, Jankovic J, Connor GS, et al. Topiramate for essential tremor. Neurology. 2006;66:672\u20137.","journal-title":"Neurology"},{"key":"239_CR22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/jnnp.42.10.904","volume":"42","author":"D Jefferson","year":"1979","unstructured":"Jefferson D, Jenner P, Marsden CD. beta-Adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry. 1979;42:904\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"239_CR23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jnnp.46.8.710","volume":"46","author":"PN Leigh","year":"1983","unstructured":"Leigh PN, Jefferson D, Twomey A, Marsden CD. Beta-adrenoreceptor mechanisms in essential tremor: a double-blind placebo controlled trial of metoprolol, sotalol, and atenolol. J Neurol Neurosurg Psychiatry. 1983;46(8):710\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"239_CR24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-0404.1982.tb03141.x","volume":"66","author":"TA Larsen","year":"1982","unstructured":"Larsen TA, Ter\u00e4v\u00e4inen H, Calne DB. Atenolol vs propranolol in essential tremor. A controlled, quantitative study. Acta Neurol Scand. 1982;66(5):547\u201354.","journal-title":"Acta Neurol Scand"},{"issue":"8229","key":"239_CR25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(81)92276-5","volume":"1","author":"PN Leigh","year":"1981","unstructured":"Leigh PN, Marsden CD, Twomey A, Jefferson D. beta-Adrenoceptor antagonists and essential tremor. Lancet. 1981;1(8229):1106.","journal-title":"Lancet"},{"issue":"4","key":"239_CR26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2125.1985.tb05079.x","volume":"20","author":"B Abila","year":"1985","unstructured":"Abila B, Wilson JF, Marshall RW, Richens A. The tremorolytic action of beta-adrenoceptor blockers in essential, physiological, and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartment. Br J Clin Pharmacol. 1985;20(4):369\u201376.","journal-title":"Br J Clin Pharmacol"},{"key":"239_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s100720070069","volume":"21","author":"DI Gunal","year":"2000","unstructured":"Gunal DI, Afsar N, Bekiroglu N, et al. New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide. Neurol Sci. 2000;21:315\u20137.","journal-title":"Neurol Sci"},{"key":"239_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/WNL.38.2.241","volume":"38","author":"SJ Huber","year":"1988","unstructured":"Huber SJ, Paulson GW. Efficacy of alprazolam for essential tremor. Neurology. 1988;38:241\u20133.","journal-title":"Neurology"},{"key":"239_CR29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.33.8.1076","volume":"33","author":"WC Koller","year":"1983","unstructured":"Koller WC. Nadolol in essential tremor. Neurology. 1983;33:1076\u20137.","journal-title":"Neurology"},{"key":"239_CR30","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.45.8.1523","volume":"45","author":"N Biary","year":"1995","unstructured":"Biary N, Bahou Y, Sofi MA, et al. The effect of nimodipine on essential tremor. Neurology. 1995;45:1523\u20135.","journal-title":"Neurology"},{"key":"239_CR31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1212\/WNL.37.3.471","volume":"37","author":"N Biary","year":"1987","unstructured":"Biary N, Koller W. Kinetic predominant essential tremor: successful treatment with clonazepam. Neurology. 1987;37:471\u20134.","journal-title":"Neurology"},{"issue":"11","key":"239_CR32","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mds.21629","volume":"22","author":"TA Zesiewicz","year":"2007","unstructured":"Zesiewicz TA, Ward CL, Hauser RA, et al. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord. 2007;22(11):1660\u20133.","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"239_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jns.2009.06.044","volume":"285","author":"JM Ferrara","year":"2009","unstructured":"Ferrara JM, Kenney C, Davidson AL, et al. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci. 2009;285(1\u20132):195\u20137.","journal-title":"J Neurol Sci"},{"issue":"2","key":"239_CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mds.25264","volume":"28","author":"TA Zesiewicz","year":"2012","unstructured":"Zesiewicz TA, Sullivan KL, Hinson V, et al. Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor. Mov Disord. 2012;28(2):249\u201350.","journal-title":"Mov Disord"},{"issue":"19","key":"239_CR35","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","volume":"77","author":"TA Zesiewicz","year":"2011","unstructured":"Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2011;77(19):1752\u20135.","journal-title":"Neurology"},{"issue":"6","key":"239_CR36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNF.0b013E31807A32C6","volume":"30","author":"RJ Elble","year":"2007","unstructured":"Elble RJ, Lyons KE, Pahwa R. Levetiracetam is not effective for essential tremor. Clin Neuropharmacol. 2007;30(6):350\u20136.","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"239_CR37","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/mds.20147","volume":"19","author":"A Handforth","year":"2004","unstructured":"Handforth A, Martin FC. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor. Mov Disord. 2004;19(10):1215\u201321.","journal-title":"Mov Disord"},{"key":"239_CR38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1212\/01.WNL.0000154596.21335.2E","volume":"64","author":"KO Bushara","year":"2005","unstructured":"Bushara KO, Malik T, Exconde RE. The effect of levetiracetam on essential tremor. Neurology. 2005;64:1078\u201380.","journal-title":"Neurology"},{"key":"239_CR39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","volume":"56","author":"A Gironell","year":"1999","unstructured":"Gironell A, Kulisevsky J, Barbonoj M, et al. A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol. 1999;56:475\u201380.","journal-title":"Arch Neurol"},{"key":"239_CR40","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","volume":"15","author":"W Ondo","year":"2000","unstructured":"Ondo W, Hunter C, Vuong KD, et al. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord. 2000;15:678\u201382.","journal-title":"Mov Disord"},{"key":"239_CR41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","volume":"13","author":"R Pahwa","year":"1998","unstructured":"Pahwa R, Lyons K, Hubble JP, et al. Double-blind, controlled trial of gabapentin in essential tremor. Mov Disord. 1998;13:465\u20137.","journal-title":"Mov Disord"},{"key":"239_CR42","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jnnp.44.9.814","volume":"44","author":"S Calzetti","year":"1981","unstructured":"Calzetti S, Findley LJ, Gresty MA, et al. Metoprolol and propranolol in essential tremor: a double-blind, controlled study. J Neurol Neurosurg Psychiatry. 1981;44:814\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"239_CR43","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/jnnp.45.10.893","volume":"45","author":"S Calzetti","year":"1982","unstructured":"Calzetti S, Findley LJ, Perucca E, et al. Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. J Neurol Neurosurg Psychiatry. 1982;45:893\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"239_CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2004.09.004","volume":"11","author":"S Morita","year":"2005","unstructured":"Morita S, Miwa H, Kondo T. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord. 2005;11:101\u20133.","journal-title":"Parkinsonism Relat Disord"},{"key":"239_CR45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.21282","volume":"22","author":"TA Zesiewicz","year":"2007","unstructured":"Zesiewicz TA, Ward CL, Hauser RA, et al. A double-blind placebo controlled trial of zonisamide (Zonegran) in the treatment of essential tremor. Mov Disord. 2007;22:279\u201382.","journal-title":"Mov Disord"},{"key":"239_CR46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.22418","volume":"24","author":"A Handforth","year":"2009","unstructured":"Handforth A, Martin FC, Kang GA, et al. Zonisamide for essential tremor: an evaluator-blinded study. Mov Disord. 2009;24:437\u201340.","journal-title":"Mov Disord"},{"issue":"5","key":"239_CR47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1756285609338501","volume":"2","author":"PE Bermejo","year":"2009","unstructured":"Bermejo PE, Anciones B. A review of the use of Zonisamide in Parkinson\u2019s Disease. Ther Adv Neurol Disord. 2009;2(5):313\u20137.","journal-title":"Ther Adv Neurol Disord"},{"key":"239_CR48","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","volume":"56","author":"MF Brin","year":"2001","unstructured":"Brin MF, Lyons KE, Doucette J, et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001;56:1523\u20138.","journal-title":"Neurology"},{"key":"239_CR49","doi-asserted-by":"crossref","unstructured":"Favilla CG, Topoil DD, et al. Impact of discontinuing tremor suppressing medications following thalamic deep brain stimulation. Parkinsonism Related Disord. 2013;19(2):171\u20135.","DOI":"10.1016\/j.parkreldis.2012.09.002"},{"key":"239_CR50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000338683","volume":"90","author":"TH Oliveira de","year":"2012","unstructured":"de Oliveira TH, Ginsberg MR. Long-term effects of deep brain stimulation for essential tremor with subjective and objective quantification via mailed-in questionnaires. Stereotact Funct Neurosurg. 2012;90:394\u2013400.","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"239_CR51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3171\/2012.3.JNS112316","volume":"117","author":"JM Nazzaro","year":"2012","unstructured":"Nazzaro JM, Pathwa R, Lyons KE. Long-term benefits in quality of life after unilateral thalamic deep brain stimulation for essential tremor. J Neurosurg. 2012;117(1):156\u201361.","journal-title":"J Neurosurg"},{"key":"239_CR52","doi-asserted-by":"crossref","unstructured":"Timmermann L, Schupbachn M, Hertel F, et al. A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey. Eur Neurol. 2013;69(4):193\u20139.","DOI":"10.1159\/000342236"},{"key":"239_CR53","doi-asserted-by":"crossref","unstructured":"Carvallo JF, Mostile G, Almaguer M, et al. Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations. Stereotact Funct Neurosurg. 2012;90:300\u20136.","DOI":"10.1159\/000338222"},{"key":"239_CR54","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson\u2019s Disease. N Engl J Med. 2006;355:896\u2013908.","journal-title":"N Engl J Med"},{"issue":"5","key":"239_CR55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/02688690701552278","volume":"21","author":"P Blomstedt","year":"2007","unstructured":"Blomstedt P, Hariz GM, Hariz MI, Koskinen LO. Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up. Br J Neurosurg. 2007;21(5):504\u20139.","journal-title":"Br J Neurosurg"},{"issue":"4","key":"239_CR56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3171\/JNS\/2008\/109\/10\/0640","volume":"109","author":"JG Pilitsis","year":"2008","unstructured":"Pilitsis JG, Metman LV, Toleikis JR, Hughes LE, Sani SB, Bakay RA. Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor. J Neurosurg. 2008;109(4):640\u20136.","journal-title":"J Neurosurg"},{"key":"239_CR57","doi-asserted-by":"crossref","unstructured":"Favilla CG, Ullman D, Wagle Shukla A, et al. Worsening essential tremor following deep brain stimulation: disease progression vs tolerance. Brain. 2012;135(5):1455\u201362.","DOI":"10.1093\/brain\/aws026"},{"key":"239_CR58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.1089","volume":"16","author":"WC Koller","year":"2001","unstructured":"Koller WC, Lyons KE, Wilkinson SB, et al. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord. 2001;16:464\u20138.","journal-title":"Mov Disord"},{"key":"239_CR59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3171\/jns.2006.104.4.506","volume":"104","author":"R Pahwa","year":"2006","unstructured":"Pahwa R, Lyons KE, Wilkinson SB. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006;104:506\u201312.","journal-title":"J Neurosurg"},{"key":"239_CR60","doi-asserted-by":"crossref","unstructured":"Keane M, Deyo S, Abosch A, Keane M, Deyo S, Abosch A, et al. Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor. J Neural Eng. 2012;9(4):046005. doi: 10.1088\/1741-2560\/9\/4\/046005 .","DOI":"10.1088\/1741-2560\/9\/4\/046005"},{"issue":"1\u20134","key":"239_CR61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000098966","volume":"58","author":"MS Goldman","year":"1992","unstructured":"Goldman MS, Kelly PJ. Stereotactic thalamotomy for medically intractable essential tremor. Stereotact Funct Neurosurg. 1992;58(1\u20134):22\u20135.","journal-title":"Stereotact Funct Neurosurg"},{"issue":"2\u20134","key":"239_CR62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000029722","volume":"72","author":"MC Akbostanci","year":"1999","unstructured":"Akbostanci MC, Slavin KV, Burchiel KJ. Stereotactic ventral intermedial thalamotomy for the treatment of essential tremor: results of a series of 37 patients. Stereotact Funct Neurosurg. 1999;72(2\u20134):174\u20137.","journal-title":"Stereotact Funct Neurosurg"},{"key":"239_CR63","doi-asserted-by":"crossref","unstructured":"Burneo J. Neurology: an evidence-based approach. Springer. 2012;138\u20139.","DOI":"10.1007\/978-0-387-88555-1"},{"key":"239_CR64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7819-8-61","volume":"8","author":"AL Elaimy","year":"2010","unstructured":"Elaimy AL, Arthurs BJ, Lamoreaux WT, et al. Gamma knife radiosurgery for movement disorders: a concise review of the literature. World J Surg Oncol. 2010;8:61.","journal-title":"World J Surg Oncol"},{"key":"239_CR65","doi-asserted-by":"crossref","unstructured":"Kooshkabadi A. Gamma knife thalamotomy for tremor in the magnetic resonance imaging era. J Neurosurg. 2013; [epub].","DOI":"10.3171\/2013.1.JNS121111"},{"issue":"3","key":"239_CR66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1227\/NEU.0b013e3182350893","volume":"70","author":"C Ohye","year":"2012","unstructured":"Ohye C, Higuchi Y, et al. Gamma knife thalamotomy for Parkinson disease and essential tremor: a prospective multicenter study. Neurosurgery. 2012;70(3):535\u20136.","journal-title":"Neurosurgery"},{"key":"239_CR67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archneurol.2010.69","volume":"67","author":"SY Lim","year":"2010","unstructured":"Lim SY, Hodaie M, Fallis M, et al. Gamma knife thalamotomy for disabling tremor: a blinded evaluation. Arch Neurol. 2010;67:584\u20138.","journal-title":"Arch Neurol"},{"issue":"12","key":"239_CR68","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/archneur.58.12.1995","volume":"58","author":"MS Okun","year":"2001","unstructured":"Okun MS, Stover NP, Subramanian T, Gearing M, Wainer BH, Holder CA, et al. Complications of gamma knife surgery for Parkinson disease. Arch Neurol. 2001;58(12):1995\u20132002.","journal-title":"Arch Neurol"},{"issue":"6","key":"239_CR69","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3171\/2009.10.JNS09332","volume":"112","author":"RF Young","year":"2010","unstructured":"Young RF, Li F, et al. Gamma Knife thalamotomy for treatment of essential tremor: long-term results. J Neurosurg. 2010;112(6):1311\u20137.","journal-title":"J Neurosurg"},{"key":"239_CR70","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","volume":"39","author":"WC Koller","year":"1989","unstructured":"Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology. 1989;39:1587\u20138.","journal-title":"Neurology"},{"key":"239_CR71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002826-199002000-00007","volume":"13","author":"E Sasso","year":"1990","unstructured":"Sasso E, Perucca E, Fava R, Calzetti S. Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. Clin Neuropharmacol. 1990;13:67\u201376.","journal-title":"Clin Neuropharmacol"},{"key":"239_CR72","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1600-0404.1990.tb00982.x","volume":"81","author":"S Calzetti","year":"1990","unstructured":"Calzetti S, Sasso E, Baratti M, Fava R. Clinical and computer-based assessment of long-term therapeutic efficacy of propranolol in essential tremor. Acta Neurol Scand. 1990;81:392\u20136.","journal-title":"Acta Neurol Scand"},{"key":"239_CR73","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.parkreldis.2005.05.009","volume":"11","author":"T Al","year":"2005","unstructured":"Al T, Pahwa R, Fields JA, Tanner CM, Lyons KE. Quality of life in essential tremor questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord. 2005;11:367\u201373.","journal-title":"Parkinsonism Relat Disord"},{"key":"239_CR74","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jclinepi.2009.09.001","volume":"63","author":"P Martinez-Martin","year":"2010","unstructured":"Martinez-Martin P, Jimenez-Jimenez FJ, Carroza GE, et al. Most of the quality of life in essential tremor questionnaire (QUEST) psychometric properties resulted in satisfactory values. J Clin Epidemiol. 2010;63:767\u201373.","journal-title":"J Clin Epidemiol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0239-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-013-0239-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-013-0239-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T01:23:09Z","timestamp":1563499389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-013-0239-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1007\/s11940-013-0239-4","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]}}}